English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Results According to our findings, serum prolactin levels in prolactinoma before and after the cabergoline treatment were significantly different (128.0±99.7 vs 35.5±39.5 ng/ml, p=0.0001, respectively). Mean cumulative cabergoline dose were calculated as 218.1±252.5 mg. We found that the mean pre-treatment MPV values in prolactinoma group were lower than post-treatment MPV values (8.9±0.8 and 9.6±0.8 fL, p=0.0001, respectively) and lower than control group (8.9±0.8 and 9.8±0,9 fL, p=0.0001, respectively). There was no correlation both between posttreatment MPV and CCD. Moreover, there were not any relationships between MPV and both prolactin levels before and after the treatment.

High mean platelet volume in prolactinoma treated with cabergoline